89 related articles for article (PubMed ID: 24317684)
1. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR.
Tennstedt P; Bölch C; Strobel G; Minner S; Burkhardt L; Grob T; Masser S; Sauter G; Schlomm T; Simon R
Int J Oncol; 2014 Feb; 44(2):609-15. PubMed ID: 24317684
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
[TBL] [Abstract][Full Text] [Related]
3. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
Byrne JA; Balleine RL; Schoenberg Fejzo M; Mercieca J; Chiew YE; Livnat Y; St Heaps L; Peters GB; Byth K; Karlan BY; Slamon DJ; Harnett P; Defazio A
Int J Cancer; 2005 Dec; 117(6):1049-54. PubMed ID: 15986428
[TBL] [Abstract][Full Text] [Related]
4. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA
Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023
[TBL] [Abstract][Full Text] [Related]
5. A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins.
Cao Q; Chen J; Zhu L; Liu Y; Zhou Z; Sha J; Wang S; Li J
Biochem Biophys Res Commun; 2006 Jun; 344(3):798-806. PubMed ID: 16631610
[TBL] [Abstract][Full Text] [Related]
6. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
[TBL] [Abstract][Full Text] [Related]
7. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
Rubin MA; Varambally S; Beroukhim R; Tomlins SA; Rhodes DR; Paris PL; Hofer MD; Storz-Schweizer M; Kuefer R; Fletcher JA; Hsi BL; Byrne JA; Pienta KJ; Collins C; Sellers WR; Chinnaiyan AM
Cancer Res; 2004 Jun; 64(11):3814-22. PubMed ID: 15172988
[TBL] [Abstract][Full Text] [Related]
8. Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
Byrne JA; Frost S; Chen Y; Bright RK
Tumour Biol; 2014 Aug; 35(8):7369-82. PubMed ID: 24798974
[TBL] [Abstract][Full Text] [Related]
9. Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system.
Wilson SH; Bailey AM; Nourse CR; Mattei MG; Byrne JA
Genomics; 2001 Aug; 76(1-3):81-8. PubMed ID: 11549320
[TBL] [Abstract][Full Text] [Related]
10. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
11. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
[TBL] [Abstract][Full Text] [Related]
12. Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.
Bagley RG; Rouleau C; Weber W; Mehraein K; Smale R; Curiel M; Callahan M; Roy A; Boutin P; St Martin T; Nacht M; Teicher BA
Microvasc Res; 2011 Nov; 82(3):253-62. PubMed ID: 21958527
[TBL] [Abstract][Full Text] [Related]
13. Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration.
Dasari C; Reddy KRK; Natani S; Murthy TRL; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1298-1309. PubMed ID: 30981892
[TBL] [Abstract][Full Text] [Related]
14. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
[TBL] [Abstract][Full Text] [Related]
15. Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52).
Byrne JA; Mattei MG; Basset P
Genomics; 1996 Aug; 35(3):523-32. PubMed ID: 8812487
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
17. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
[TBL] [Abstract][Full Text] [Related]
18. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
Wang R; Xu J; Saramäki O; Visakorpi T; Sutherland WM; Zhou J; Sen B; Lim SD; Mabjeesh N; Amin M; Dong JT; Petros JA; Nelson PS; Marshall FF; Zhau HE; Chung LW
Cancer Res; 2004 Mar; 64(5):1589-94. PubMed ID: 14996714
[TBL] [Abstract][Full Text] [Related]
19. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.
Banham AH; Beasley N; Campo E; Fernandez PL; Fidler C; Gatter K; Jones M; Mason DY; Prime JE; Trougouboff P; Wood K; Cordell JL
Cancer Res; 2001 Dec; 61(24):8820-9. PubMed ID: 11751404
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
